Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

EV 104

Next Previous
X
Search
Drug Profile

EV 104

Alternative Names: Cannabidiol-celecoxib; EV 104a; EV 104b; EV-104

Latest Information Update: 10 Feb 2022

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Diverse Biotech
  • Developer Enveric Biosciences
  • Class Analgesics; Anti-inflammatories; Cannabinoids; Cyclohexenes; Drug conjugates; Nonsteroidal anti-inflammatories; Pyrazoles; Small molecules; Sulfonamides
  • Mechanism of Action 5-HT1 serotonin receptor modulators; Cannabinoid receptor CB1 agonists; Cannabinoid receptor CB2 agonists; Cyclo-oxygenase 2 inhibitors; Transient receptor potential channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Pain

Most Recent Events

  • 08 Feb 2022 Enveric Biosciences files for patent protection with the US Patents and Trademark Office for EV 104 (Cannabinoid-Celecoxib conjugate) in USA before February 2022
  • 08 Feb 2022 Preclinical trials in Pain in Italy (Topical) before February 2022
  • 14 Sep 2021 EV 104 is available for licensing as of 14 Sep 2021. https://www.enveric.com/contact/partnership-inquiries/

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top